G P Vlasuk

2.6k citations
36 papers · 2.2k indexed · h-index 25

G P Vlasuk

36 papers receiving 2.1k citations

Peers

G P Vlasuk
Comparison fields: 5 of 96
  • Internal Medicine 239
  • Hematology 642
  • Parasitology 288
  • Cardiology and Cardiovascular Medicine 513
  • Genetics 211
Replace Norbel Galanti with:
Norbel Galanti Chile
Júlio Scharfstein Brazil
Katsuyuki Yui Japan
Zoltán Óváry United States
Marcello A. Barcinski Brazil
Qiumin Lu China
Patrick Lécine France
Masashi Fukasawa Japan
Nora Bijl Netherlands
Evelyne Jouvin‐Marche France
G P Vlasuk relative to Norbel Galanti Chile Norbel Galanti's profile →
Citations per field
00.5×8.1×
Norbel Galanti · 1×
Citations per year

Countries citing papers authored by G P Vlasuk

Since Specialization
Citations

This map shows the geographic impact of G P Vlasuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G P Vlasuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G P Vlasuk more than expected).

Fields of papers citing papers by G P Vlasuk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G P Vlasuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G P Vlasuk. The network helps show where G P Vlasuk may publish in the future.

Co-authorship network

The 25 scholars most cited alongside G P Vlasuk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with G P Vlasuk Line = papers co-authored together G P Vlasuk links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 200910
2 200851
3 200432
4 200366
5 20021
6 200218
7 199433
8 199234
9 1992113
10 199229
11 199126
12 199034
13 199091
14 198710
15
Cloning, sequence analysis, and processing of the rat and human atrial natriuretic peptide precursors.
198620
16 1985125
17 198424
18 198261
19 198020
20 197128

About G P Vlasuk

G P Vlasuk is a scholar working on Internal Medicine, Hematology and Cardiology and Cardiovascular Medicine, having authored 36 papers that have together received 2.2k indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (13 papers), Venous Thromboembolism Diagnosis and Management (8 papers), RNA and protein synthesis mechanisms (4 papers), Bacterial Genetics and Biotechnology (4 papers), Atrial Fibrillation Management and Outcomes (3 papers), Heart Failure Treatment and Management (3 papers), Hemophilia Treatment and Research (3 papers) and Insect Resistance and Genetics (3 papers). The work is most often cited by research in Internal Medicine (239 citations), Hematology (642 citations) and Parasitology (288 citations). G P Vlasuk has collaborated with scholars based in United States, Canada and India. Frequent co-authors include Lloyd Waxman, Donna Smith, Karen E. Arcuri, Peter W. Bergum, Masayori Inouye, S Inouye, Michael Cappello, Curtis J. Omiecinski, Peter J. Hotez and Hirataka Ito. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026